Genomma Lab Executes Dividend Payout of 200 Million Pesos

The payout equates to 0.20 Mexican pesos per share for all outstanding common stock listed on the Bolsa Mexicana de Valores under the ticker LABB. This distribution follows the specific authorization granted during the Annual General Shareholders Meeting held on April 24, 2025, which delegated the necessary powers to the Board to manage the company's dividend policy.

Management indicated that the company intends to maintain this quarterly cadence for future dividend payments, pending further board review and market conditions. Genomma Lab, a major player in the pharmaceutical and personal care sectors across Latin America, continues to leverage its flexible supply chain and marketing-heavy business model to sustain these distributions while navigating the broader economic landscape.